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Abstract
Streptococcus pneumoniae (the pneumococcus) is a formidable human pathogen, responsible for massive global morbidity
and mortality. The ability to utilize carbohydrates in a variety of host niches appears to be integral to pneumococcal
pathogenesis. In this study we investigated a genomic island, which includes a ROK family protein, a putative cellobiose
phosphotransferase system (PTS) and a putative sulfatase. This accessory region is widespread in the pneumococcus in
strains of various serotypes and levels of virulence. We have performed simple bioinformatic analysis of the region and
investigated its role in vivo in 2 strains with markedly different virulence profiles (WCH206 of serotype 3, ST180; Menzies5 of
serotype 11A, ST662). Deleting and replacing the entire island with an antibiotic resistance cassette caused the virulent
serotype 3 strain to become attenuated in a murine pneumonia/sepsis model. Further mutants were constructed and used
to show that various components of the island contribute significantly to the fitness of WCH206 in a variety of niches of this
model, including the nasopharynx, ears and blood, but especially in the lungs. In addition, the island conferred a
competitive advantage in nasopharyngeal colonization for the serotype 11A strain, which was essentially avirulent in the
pneumonia/sepsis model. The contribution of this island to both pathogenesis and colonization may explain why this
accessory region is widespread in the pneumococcus.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is a formidable
pathogen, which is the principal bacterial cause of pneumonia,
sepsis and otitis media (OM), and responsible for more deaths
worldwide than any other bacterium. The polysaccharide capsule
is a sine qua non of virulence and defines the serotype of which there
are over 90 identified to date. Nevertheless, additional non-
capsular factors also play an integral role in pathogenesis. S.
pneumoniae carries a large number of sugar transporters, which have
been proposed to help it occupy unique in vivo micro-environ-
mental niches [1]. However, little is known about pneumococcal
carbohydrate utilization and metabolism in these environments
[2]. Sugar transporters have been identified during signature-
tagged mutagenesis virulence factor screens [3,4,5,6], and several
defined transporter mutants have been shown to be attenuated in
vivo [2,7]. This indicates that despite the large number of sugar
transporters, the removal of even one can have a measurable
impact on virulence.
Some systems appear to be functionally conserved in the
pneumococcus, such as the well-characterized neuraminidase
NanA or the Sus and Scr sucrose utilization systems, although
there can be sequence variation between strains [2,8]. There are
also carbohydrate utilisation systems encoded on accessory regions
that are not uniformly distributed amongst strains [1,9,10,11,12].
McKessar and Hakenbeck have previously described an accessory
region (the cel locus) containing a cellobiose phosphotransferase
system (PTS) [13], whose components were also identified during
a signature-tagged mutagenesis study using an otitis media model
[6]. In this study we examined an alternative accessory region
harbouring a putative cellobiose phosphotransferase system (PTS),
which has been previously described as being absent in D39 and
TIGR4 and hypothesised to be involved in virulence
[14,15,16,17,18]. Despite its absence in D39 and TIGR4, this
PTS was present in four distinct serotype 3 isolates (Menzies11 and
Menzies17 of ST458, and WCH206 and WCH207 of ST180),
which were highly virulent in a mouse sepsis model, but absent in
the significantly less virulent serotype 3 strain WU2 (ST378) [18].
However, as with the cel locus, we found that this system is present
in a wide range of pneumococcal isolates belonging to diverse
serotypes (over 80% of those tested), including unrelated avirulent
isolates of serogroup 11 [18]. The PTS is part of a larger 10 kb
island (see Fig. 1), which also encodes a ROK family protein, a
putative sulfatase (arylsulfatase) and a putative sulfatase modifying
factor, as well as a couple of hypothetical proteins [14,16,17,18].
The ROK family comprises transcriptional repressors, ORFs of
unknown function and sugar kinases in bacteria, and includes a
xylose repressor from Bacillus subtilis,aN-acetylglucosamine
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kinase from S. mutans [19]. In contrast, sulfatases are highly
conserved across eukaryotes and prokaryotes and are believed to
be used by prokaryotes to hydrolyse sulphate ester groups from
proteoglycans, glycosaminoglycans (GAGs) and choline sulphate
[20]. They are normally associated with a sulfatase-modifying
factor [21], which is required to catalyse the post-translational
activation of the sulfatase, an unusual feature for prokaryotic
proteins [22]. There are many other pneumococcal sugar
transporters also associated with hydrolases, but this particular
system is interesting in that some strains, including G54 and
serotype 3 isolates of ST458 (Menzies11 and Menzies17), have a
deletion removing the sulfatase, as well as parts of the sulfatase
modifying factor and the last gene of the PTS operon [18]. Due to
the prevalence of this island and its interesting annotation, in this
study we have constructed mutants of the island in two distinct S.
pneumoniae genetic backgrounds and investigated the impact on
phenotype in vivo.
Results
Bioinformatic analysis
We commenced by performing simple bioinformatic analysis of
the various components of the AR. We observed that the ROK
family protein does not appear to have the characteristic binding
motif described by Titgemeyer et al. (1994), yet its size suggests it is
more likely to be a repressor than a kinase [19]. A BLAST-p
search revealed a NagC domain, but no DNA binding motif. In
contrast, when the amino acid sequence of NagC from E. coli K12
(NC_000913) was examined, a MarR (repressor of the multiple
drug resistance operon) family motif was detectable at the N-
terminus. Interestingly, a Pfam search using the same sequences
identified a MarR family motif in both proteins at the N-terminus,
which was a significant match for NagC, but insignificant for the
pneumococcal ROK family protein. HHPred indicated there is
helix-turn-helix domain at the N-terminus of the pneumococcal
ROK family protein and the best 3 matches, which had
probabilities of 100 and E and P values of 0, were the well-
characterised Mlc repressor of E. coli, which is homologous to
NagC, an Mlc homolog of Vibrio cholerae and a putative N-
acetylmannosamine repressor of Thermotoga maritima (also annotat-
ed as N-acetylglucosamine kinase). Interestingly, Pfam searches
using the amino acid sequences of these 3 matches identified
insignificant matches for the iron dependent repressor family, the
MarR family and the MarR 2 family, respectively.
A BLAST-p search of various components of the putative
cellobiose PTS revealed it belongs to the Lactose-N,N9-
Diacetylchitobiose b-glucoside (Lac) family (Family 4.A.3), which
is a family of b-glucoside, cellobiose and chitin disaccharide
(N, N9-diacetylchitobiose) transporters. The hypothetical protein
associated with the PTS components has been annotated as PEP
phosphonomutase-like protein in some pneumococci. A HHpred
search revealed the highest homology with inosine-59-mono-
phosphate dehydrogenase, GMP reductase 2 and most interest-
ingly, N-acetylmannosamine-6-phosphate 2-epimerase 2 (proba-
bilities greater than 99%).
Finally, HHPred analysis of the sulfatases identified homology
(probability of 100, P and E values of 0) with other sulfatases as
expected, as well as a phosphonate monoester hydrolase (from
Rhizobium leguminosarum) and an alkaline phosphatase (from
Antarctic bacterium TAB5). Interestingly, the hypothetical protein
encoded adjacent to the sulfatase-modifying factor has a significant
Pfam match with the TauE family (sulfite exporter TauE/SafE).
Mutational analysis
To examine the phenotypic contribution of the genomic island
encoding the putative cellobiose PTS, an in-frame, deletion-
replacement mutant in the serotype 3 OM isolate WCH206
(ST180), designated WCH206 DIsland, was constructed by
removing and replacing the entire island with an erythromycin
resistance cassette attached to the promoter of the serotype 2
capsule locus, as described in the Materials and Methods and
shown in Figure 1. This erythromycin resistance cassette has
been previously used to construct nonpolar mutants of the
capsular biosynthesis locus in D39 [23]. The orientation of the
genes of the accessory region necessitated the inclusion of a
promoter to allow expression of the erythromycin resistance gene,
which is why the cassette was amplified from the mutant D39-
ABDe [23] to include the capsule locus promoter. Following
confirmation of the mutation by sequencing, opaque variants were
selected for all experiments, except the biofilm assay and
colonisation competition study for which transparent pneumococci
were preferred.
Initially, the mutant was examined for alterations in both
planktonic and biofilm growth, as well as sugar fermentation. The
numbers of biofilm-forming and planktonic bacteria were
determined for WCH206 and WCH206 DIsland on days 1, 2, 4
and 7 in triplicate samples grown in 0.56BHI. No significant
differences in the growth characteristics or numbers of planktonic
or biofilm-associated bacteria were observed at the time points
examined (Figure 2). Fermentation of cellobiose by WCH206
and WCH206 DIsland grown in THY to mid-exponential phase
was also investigated in two independent experiments, using the
purple broth assay with sucrose as the positive control (see
Materials and Methods). There was no difference between wild-
type and mutant in their capacity to ferment cellobiose, although
the colour change observed was less than that for sucrose (data not
Figure 1. Organisation of the PTS island and location of mutagenesis deletions. Genes sph1922/spnoxc15810 – sph1930/spnoxc15890 of
S. pneumoniae Hungary 19A-6 and OXC141 (serotype 3, ST180), which are present in our strains WCH206 and Menzies5, are represented. The
locations of the various deletion mutants constructed in this study are indicated.
doi:10.1371/journal.pone.0032385.g001
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locus [24]. We cultured the mutant and wild-type in M17
supplemented with 5% (w/v) glucose, cellobiose or lactose. The
previous observation that the PTS belongs to the Lactose-N, N9-
diacetylchitobiose b-glucoside (Lac) family was the reasoning
behind the inclusion of lactose. Although removing the island did
not retard growth in these media (data not shown), growth in the
cellobiose supplemented media was very poor compared to the
other two media and neither strain grew over A600 0.3 in the
cellobiose supplemented media when the culture was started from
BA. In addition to the growth assays, a sulfatase assay was
performed using the WCH206 and WCH206 DIsland strains with
4-methylumbelliferyl sulfate as the substrate and limpet sulfatase as
the positive control [25]. However, no activity was detectable
under the conditions used in this study, even when undiluted lysate
was used. The limpet sulfatase was still capable of cleaving 4-
methylumbelliferyl sulfate when added to lysate of WCH206
suggesting there were no inhibitors of sulfatase activity present in
the lysate.
Effects on virulence were then assessed using i.p. and
pneumonia/sepsis murine models. In a direct i.p. (sepsis) challenge
model, the median survival time of mice challenged with
WCH206 DIsland was not significantly different from that for
mice challenged with the otherwise isogenic wild-type strain
(Figure 3A). As subtle differences in virulence could be masked
due to host-to-host variation, we then compared the mutant and
wild-type in a mixed infection model (i.p. competition), and found
the mutant was significantly attenuated at 48 h post-infection
(P=0.0252) (Figure 3B). In the pneumonia/sepsis model, where
mice were inoculated intranasally (i.n.) under anaesthetic, there
was a significant increase in the median survival time for mice
infected with the WCH206 DIsland mutant compared to the wild-
type (P,0.001) (Figure 4). Taken together, the results from the i.p
and i.n. studies suggest that the genomic island encoding the PTS
system plays a significant role in pneumonia and sepsis.
The ability of WCH206 DIsland to colonize the nasopharynx
of mice was also examined. Mice were inoculated intranasally
without anaesthesia and the nasopharynx was washed and
nasopharyngeal tissue removed and homogenized 1, 2, 4 and 7
days post-inoculation. Data from the nasopharyngeal wash and
homogenate were combined. The mutant was found to be
significantly attenuated compared to wild-type WCH206 strain
on day 1; log10CI values were less than 0 on days 2 and 4 as well,
but this did not reach statistical significance (Figure 5A). As
serogroup 11 strains had previously been found to colonize at
higher numbers on days 1 and 2 post-inoculation than serotype 3
strains in this model [18], we also constructed an island deletion
replacement mutant in the serotype 11A carriage isolate
Menzies5 (ST662) using the same method. Replacing the entire
island with an erythromycin cassette downstream of a capsule
locus promoter also did not affect in vitro growth of this strain,
including in M17 medium supplemented with lactose and
cellobiose, although both strains grew poorly in the presence of
cellobiose (data not shown). Infection with a mixed culture
(Menzies5 and Menzies5 DIsland) was performed and the
competitive indices in the nasopharynx calculated. The mutant
was significantly attenuated compared to the wild-type at all time
points for Menzies5 (Figure 5B).
Since the mutants described above had deletions of the entire
island, we sought to determine which individual components of
this region were responsible for the attenuation. For this purpose,
non-polar deletion replacement mutants of the various compo-
nents were constructed using the previously described erythromy-
cin resistance cassette without the inclusion of the D39 capsule
locus promoter. The first mutation was a deletion of the ROK
family protein, the second was of the putative cellobiose PTS and
associated hypothetical protein, and the third was of the sulfatase
and the sulfatase modifying factor genes (see Figure 1). Mutants
were constructed for both Menzies5 and WCH206, but the
mutants in Menzies5 were not ultimately used for any animal
work. However, due to the low transformability of WCH206 and
the conservation of the genes in the accessory region and flanking
areas, the erythromycin replacement mutations were amplified
from the Menzies5 mutants and introduced to competent
Figure 2. In vitro fitness of WCH206 DIsland. Biofilm and
planktonic growth of WCH206 and WCH206 DIsland in 0.56BHI was
measured over a 7 day period. Median bacterial numbers are indicated
by black, horizontal bars.
doi:10.1371/journal.pone.0032385.g002
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Following successful transformation, the erythromycin replace-
ment mutation was subsequently amplified from the WCH206
mutant and introduced to a fresh aliquot of WCH206 competent
cells to minimize the co-transformation of non-contiguous
chromosomal DNA. The second round transformant was then
confirmed by sequencing.
Opaque variants were required for the animal model. However,
there were issues in obtaining opaque for some mutants in vitro.
Therefore, a mouse passage was performed to facilitate the
isolation of opaque variants. All mutants and the wild-type strain
were similarly passaged for consistency.
These defined mutants of WCH206 showed no alteration in
their in vitro growth characteristics (data not shown). However,
examination of the transcription activity of genes in this region
revealed that the transcripts of the sulfatase and first IIC
component of the putative cellobiose PTS were increased
significantly in the DROK mutant (Figure 6), although sulfatase
activity was also not detectable for this mutant. The mutants were
subsequently assessed in a pneumonia/sepsis competition model
with the isogenic wild-type strain at 24, 48 and 72 h post-infection.
In the nasopharynx, the mean log10CI was below 0 for every
mutant at each time point, which was statistically significant for
DROK and DSulfatase on all days, for DPTS on days 1 and 3, and
for DIsland on day 2 (Figure 7). Furthermore, significant
attenuation for all mutants was observed in the lungs at all time
points (Figure 7). In the blood, where there is a high degree of
bacteremia, the DPTS mutant was significantly attenuated at all
time points; the DROK mutant was significantly attenuated on
days 1 and 2, while the DSulfatase strain was significantly
attenuated on day 3 (Figure 7). In the ears, mutants typically
displayed significant attenuation by day 3. The DSulfatase mutant
did not show statistically significant attenuation on day 3, probably
because only half of the mice had bacteria isolated from their ears
at this time point, and there was a wide spread in the log10CI
values (Figure 6).
Discussion
Previous studies have indicated the importance of sugar
transporters in pneumococcal virulence [2,3,4,5,6,7]. In this study
an accessory region including a putative cellobiose PTS, a putative
sulfatase and ROK family protein has been investigated. This
accessory region is widely distributed, but was found to be one of
the distinguishing genetic features between highly virulent strains
Figure 4. Fitness of WCH206 DIsland in the pneumonia/sepsis
model. CD-1 mice were challenged i.n. under anaesthesia with
approximately 1.2610
7 CFU/mouse of either WCH206 or WCH206
DIsland. Median survival times are indicated by black, horizontal bars
and were compared using the Mann Whitney U test (two tailed): ***,
P,0.001.
doi:10.1371/journal.pone.0032385.g004
Figure 3. Fitness of WCH206 DIsland in the i.p. mouse model.
(A) CD-1 mice were challenged i.p. with approximately 2.0610
4 CFU/
mouse of either WCH206 or WCH206 DIsland. Median survival times are
indicated by black, horizontal bars and were compared using the Mann
Whitney U test (two tailed); NS, not significant. (B) CD-1 mice were
challenged i.p. with 2610
3 CFU/mouse of a mixture of WCH206 and
WCH206 DIsland at a ratio of approximately 1:1.7. Mice were sacrificed
at 24 h and 48 h post-challenge and the ratio of wild-type to mutant
calculated to determine the log10CI. The neutral value of 0 (mutant is as
virulent as the wild-type) is indicated by a broken horizontal line.
Log10CIs less than 0 indicates that the mutant is less fit in comparison to
the wild-type. The mean log10CIs are indicated by black, horizontal bars.
One sample t-tests were used to compare the mean log10CI of each
group to the hypothetical value of 0: *, P,0.05.
doi:10.1371/journal.pone.0032385.g003
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the present study, we have examined the fitness of PTS island
mutants in various in vivo models. These studies were carried out
using mutants of two unrelated type 3 (ST180) and type 11A
(ST662) clinical isolates, with markedly different virulence profiles.
Initially the entire island was replaced with an erythromycin
resistance cassette in the serotype 3 strain WCH206 (ST180),
which is highly virulent in our i.p. and pneumonia/sepsis models.
In this background, deleting the island did not have a negative
impact on the ability to grow or form biofilms in standard
laboratory media. We also could not demonstrate differences in
the ability to ferment cellobiose or to grow in cellobiose-
supplemented M17 medium, as well as to grow in lactose-
supplemented medium, although we found growth and fermen-
tation to be poor in the presence of cellobiose in contrast to other
sugars. Lack of a sugar uptake defect phenotype could be
attributable to the presence of other complementary PTSs, such
as that described by McKessar and Hakenbeck [13]. Similarly, a
biochemical phenotype could not be assigned to the putative
sulfatase mutant.
As the DIsland mutant did not demonstrate any in vitro growth
defects, the behaviour of the mutant and wild-type were
subsequently examined in vivo. When WCH206 and WCH206
DIsland were compared in two virulence models, survival time
increased significantly for mice inoculated with the mutant in the
pneumonia-sepsis model but not the i.p. model (Figures 3A and
4). However, when the mutant and wild-type were tested in the
more sensitive i.p. competition model, the mutant was isolated less
frequently from the blood 2 days after inoculation (Figure 3B). In
addition to virulence, colonization was also investigated. A DIsland
mutant of the low-virulence serotype 11A strain Menzies5 (ST662)
was also examined, as serogroup 11 strains are better colonizers
than type 3 in the i.n. model [18]. WCH206 DIsland was
attenuated significantly in the nasopharynx on day 1 relative to the
Figure 5. Fitness of DIsland in the nasopharynx over a 7 day
period. CD-1 mice were inoculated i.n. without anaesthesia with
2610
7 CFU/mouse of a combination of WCH206 and WCH206 DIsland
(serotype 3) at a ratio of 1:4 (panel A) or 1.5610
6 CFU/ml of a
combination of Menzies5 and Menzies5 DIsland at a ratio of 9:7 (panel
B). The log10 CIs were calculated on days 1, 2, 4 and 7 for the
nasopharynx (nasopharyngeal tissue and wash combined). The neutral
value (0) is indicated by a broken, horizontal line and the mean log10 CIs
are indicated by black, horizontal bars. Log10 CI values under 0 indicate
that the mutant is less fit than the respective wild-type. One sample t-
tests were used to compare the mean log10 CI of each group to 0: *,
P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0032385.g005
Figure 6. In vitro expression of the putative cellobiose PTS and
sulfatase genes in WCH206 DROK. Data were calculated using the
2
2DDCT method with 16s rRNA acting as an internal control and
represent the fold difference between [mRNA] in WCH206 DROK
relative to WCH206. Error bars represent the 95% confidence interval. In
addition, the fold difference in [mRNA] of the first PTS IIC component
and sulfatase (annotated as CGSSp3BS71_03497 and CGSSpBS71_3467
in Sp3-BS71 [NCBI RefSeq: ZP_01817543.1]) in relation to 16s rRNA
(internal control) was calculated and compared between mutant and
wild-type using an unpaired t-test (*, P,0.05; **, P,0.01).
doi:10.1371/journal.pone.0032385.g006
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but this did not reach statistical significance (Figure 5A).
However, in the Menzies5 background, the mutant was signifi-
cantly less fit in the nasopharynx at every time point. These results
suggest that the island plays a significant role in colonization of
both strains and invasive disease caused by WCH206 (Figure 5B).
In an attempt to attribute the virulence defect of DIsland mutants
to individual genes, mutants of the ROK family protein, PTS
operon and sulfatase/sulfatase modifying factor were constructed in
WCH206. Again there was no impact on growth, but removing the
ROK family protein resulted in increased sulfatase and PTS
transcription. Bioinformatic analysis of the ROK family protein had
previously suggested it was more likely to be a repressor than a
kinase. These results are consistent with the recent demonstration
that the role of the transcriptional regulator CelR encoded on the
pneumococcal cel locus (another accessory region), is to activate
expression of both the cellobiose PTS and 6-phospho-b-glucosidase
of this locus [24]. In our study, the impact on the respective protein
levels is not known and it may be that there is also post-translational
control of expression. The loss of the PTS and sulfatase presumably
impacts the ability of WCH206 to utilize their substrate(s).
However, carbon catabolite control is essential to the fitness of
bacteria, as carbohydrates must be utilized in preferred order for
optimal growth. Therefore, loss of repression of these genes could
also be detrimental to fitness. Previously, loss of the pneumococcal
lactose-inducible b-galactosidase repressor RegM (also known as
catabolite control protein A [CcpA]) has been shown to result in
decreased fitness in vivo [26,27].
A 3 day competitive study was conducted with the various
WCH206 mutants using the pneumonia/sepsis model and the
results suggested the island is important in a variety of niches,
particularly the lungs, where there was statistically significant
attenuation for all mutants at each time point (Figure 7).
Attenuation was observed for 3 out of 4 mutants in the
nasopharynx over the 3 day period, adding further evidence for
the island playing a role in nasopharyngeal fitness. Furthermore,
this accessory region may also play a role in otitis media, as the
majority of mutants were significantly attenuated in the ears by
day 3. With regard to the impact of the various mutations on
development of bacteremia, it is possible that diminished ability to
colonize lung tissue could limit translocation into the blood and
hence the level of bacteremia. Nevertheless, the i.p. competition
study indicates that the island has an additional impact on sepsis
over and above lung colonization and lung-blood translocation.
This could not be correlated with survival, however, as mice
inoculated i.p. with WCH206 DIsland did not survive significantly
longer than those challenged with wild-type (Figure 3A). Overall,
the pneumonia/sepsis competition study demonstrates that
multiple components of the island contribute to fitness in the
various niches. This includes the putative sulfatase, even though
there are some S. pneumoniae strains, which carry a variant of the
island with a deletion in the putative sulfatase. Unfortunately, our
ST458 isolates with this deletion were not transformable in vitro,
so we were unable to assess the impact in this genetic background.
It is possible that there is another hydrolase compensating for the
loss of the putative sulfatase or the incomplete accessory region still
gives a competitive advantage in these particular strains.
The results of this study show that despite the large number of
sugar transporters in the pneumococcal genome, the removal of
even one sugar utilization system can have an impact on
virulence. Little is known about the in vivo substrates of many
of the putative pneumococcal sugar transporters, although the
hydrolases of two putative pneumococcal fucose operons have
been recently shown to target different blood group antigens [28].
The competitive advantage conferred by the PTS island in a
variety of niches suggests the substrates of the putative cellobiose
PTS and putative sulfatase of this study are present in multiple in
vivo niches. The bioinformatic analysis conducted in this study
adds further weight to the likely function of the PTS as a sugar
transporter. While it is yet to be determined whether the PTS and
putative sulfatase work together, many host sugars undergo
modifications, such as sulfation [29,30,31]. It is interesting that
the PTS belongs to the chitin disaccharide transporter family, as
although chitin is found in the outer covering of insects and
crustaceans, it is made of GlcNAc [32]. The homology of the
ROK family protein to a putative N-acetylmannosamine
repressor and that of the hypothetical protein associated with
the PTS components to N-acetylmannosamine-6-phosphate 2-
epimerase is also of interest.
Overall, the results of this study show that the pneumococcal
genomic island encoding the putative cellobiose PTS confers a
competitive advantage in both passive colonization and active
invasion models. This is not unexpected given that this region is
found in a wide variety of pneumococcal serotypes and STs,
including isolates with markedly differing virulence profiles.
However, the PTS island is not essential for virulence, and as
the island is also found in avirulent strains, the importance of the
system in pathogenesis ultimately depends on the strain back-
ground. Thus, accumulation of multiple beneficial accessory
regions, such as the one described in this study, rather than
carriage of any single specific region, is likely to determine the
human virulence characteristics of S. pneumoniae isolates.
Materials and Methods
Ethics statement
All animal experiments were approved by the Animal Ethics
Committee of the University of Adelaide (Project Number: S- 86-
2006), and complied with the Australian code of practice for the
care and use of animals for scientific purposes (7th Edition 2004)
and the South Australian Animal Welfare Act 1985. Written
consent was obtained for studies of human specimens and ethics
approval was obtained from the Human Research Ethics
Committe of the Menzies School of Health Research and
Department of Health and Families.
Bacterial strains and growth conditions
The middle ear isolate WCH206 (serotype 3, ST180),
nasopharyngeal isolate Menzies5 (serotype 11A, ST662) and the
mutant D39-ABDe have been described previously [18,23]. S.
pneumoniae strains were grown in THY (Todd-Hewitt broth
[Oxoid, Basingstoke, United Kingdom] supplemented with 1%
Bacto
TM yeast extract [Beckton, Dickinson and Company,
Franklin Lakes, NJ, USA]), serum broth (10% [v/v] donor horse
Figure 7. Competitiveness of various Island mutants in the pneumonia/sepsis model. Data are combined from duplicate experiments.
Mice were inoculated with approximately 3610
7 CFU/mouse of a combination of WCH206 and either WCH206 DROK, DPTS, DSulfatase or DIsland, at
average input ratios of 1.75, 0.5, 1.65 and 1.45, respectively. The CIs were calculated on days 1, 2 and 3 for the nasopharynx (nasopharyngeal tissue
and wash combined), lungs, blood and ears, and the mean log10 CIs are indicated by black, horizontal bars. The neutral value is 0 (indicated by a
broken, horizontal line). One sample t-tests were used to analyze the data (hypothetical value=0): *, P,0.05, **, P,0.01, ***, P,0.001.
doi:10.1371/journal.pone.0032385.g007
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M17 broth [Oxoid] supplemented with 5% (w/v) glucose (Ajax
Finechem, Sydney, Australia), lactose (Ajax Finechem) or
cellobiose (Sigma-Aldrich, St. Louis, MO, USA), or on blood
agar (BA) plates at 37uC in 95% air and 5% CO2. Erythromycin
(Ery; Roche, Mannheim, Germany), gentamicin (Sigma-Aldrich,)
and optochin (Sigma-Aldrich,) were added at concentrations of
0.2 mg/ml, 5 mg/ml and 5 mg/ml, respectively, where appropri-
ate. Pneumococci were transformed using complete transforma-
tion medium (CTM) [26,33]. Sugar fermentation assays were
carried out using BBL
TM Purple Broth Base (Beckton, Dickinson
and Company) essentially as previously described [13]. Static
Biofilm assay was performed as described previously [34], except
that 0.56BHI was used in place of THY.
DNA manipulations
Overlap extension PCR was used to construct mutants [35,36].
The primers J214 and J215 [37] were used to amplify the
erythromycin resistance gene (ery) from D39-ABDe [23]. For
DIsland mutants, Pcps F (59GGTTCGCGGGAAGTCTAC-
TAAG39) was used in place of J215 to include the cps2 promoter.
WCH206 DIsland and MSHR5 DIsland were constructed using the
primers Pcps/sph1930/31 (59CTTAGTAGACTTCCCGCGA-
ACCTATCTCCCCTTTTTCACAA TGTATAG39), sph1932
(59CCCTATATCATGGCTGGTGACC39), J215/sph1920/21
(59CGGGAGGAAATAATTCTATGAGGAAAGCAAACAGC-
CTTGAAATCAAT) and sph1914 (59CTAATTCAGTCCA-
AACTTCCAGTTC39). WCH206 DROK was constructed using
the primers J214/sph1930 (59TTGTTCATGTAATCACTCC-
TTCTAG TTGTCAGATTCTTAAAATCCTAT39), G54
spn02109 (59CCCTGTGCCTCTCTTGT CAACA39), J215/
sph1930 (59CGGGAGGAAATAATTCTATGAGACATTTAA-
TAA ATAGGCTAAAAAGAGG39) and sph1932 (59CCCTA-
TATCATGGCTGGTGACC39). WCH206 DPTS was con-
structed using the primers J214/sph1929 (59TTGTTCATG-
TAA TCACTCCTTCAAATATATTTTATTATCAAAA GT-
TATCAATTA39), sph1930 (59GTGCGGCTGTAAAATCAT-
TGTAAG39), J215/sph1925 (59CGGGAGGAAATAA TTCT-
ATGAGTTGCGTTTTTTGTGATAAAATAGAAATAGA39)
and sph1924a (59GGGGATTTAATGGAGCATGTGGT39).
WCH206 DSulfatase was constructed using J214/sph1924
(59TTGTTCATGTAATCACTCCTTCAATATGGCAAAAGA-
GG CACAAGAA 39), mRNA sph1925 PTS IIC R (see below),
J215/sph1923 (59CGGGAG GAAATAATTCTATGAGAAAA-
AGTGGTTGAGATTATTTATTTT39) and sph1919 (59AGT-
TGCCGAAGACGCTAAAGACG39). All primers were purchased
from Sigma-Aldrich. PCR reactions were carried out using the
Expand
TM Long Template or High Fidelity PCR Systems (Roche
Diagnostics) and an Eppendorf Mastercycler (Eppendorf, Ham-
burg, Germany). Mutations were confirmed by sequencing using
the primers J257 (59TTAAATGCCCTTTACCTGTTCC39)a n d
J258 (59GAAGCTATATACGTACTTTG TTTC39). DNA se-
quencing reactions were carried out using the BigDyeH Terminator
v3.1 Cycle Sequencing Kit (Applied Biosystems, California, USA).
RNA analysis
Duplicate cultures in BHI wereinoculatedfrom BA plate cultures
of each strain and grown to mid-exponential phase. RNA was
isolated and purified from bacterial pellets with acid-phenol:chlor-
oform:isoamyl alcohol (125:24:1; pH 4.5, Ambion, Austin, TX.,
USA)essentiallyasdescribed previously [38,39].Differences ingene
transcript levels was assessed by real-time RT-PCR on a Rotorgene
RG-2000 (Corbett Research, Mortlake, NSW, Australia) using the
Invitrogen SuperScript
TM III PlatinumH SYBRH Green One-Step
qRT-PCR kit. A primer set specific for 16S rRNA (mRNA
spd0016 16s F 59GAGCTTGCTTCTCTGGATGAGTTG39,
mRNA spd0016 16s R 59GTGATGCAAGTGCACCTTT-
TAAGC39) was used as internal controls for data normalization.
Transcripts of the cellobiose PTS were measured using mRNA
sph1929 PTSIIC F (59ACCTCCCAAAGCTACTTGAGC-
AAT39) and mRNA sph1929 PTSIIC R (59GATGGTGTTC-
CACCAGCAGTATCT39). Transcripts of the sulfatase were
measured using mRNA sph1924 sulfatase F (59CAATA-
AAGCTGCCCTAGCAGGAA C39) and mRNA sph1924 sulfa-
tase R (59GATCAAATGAGAGCAGACGCCTTA39). Quanti-
tative fold differences for each transcript were determined using
the 2
2DDCT method [40].
Virulence and pathogenesis studies
Each animal experiment used outbred 5–6 week old CD-1
(Swiss) mice and was approved by the Animal Ethics Committee of
the University of Adelaide. For intraperitoneal (i.p.) and
pneumonia/sepsis models, opaque variants were cultured in SB
to approximately 1610
8 CFU/ml (A600=0.16), followed by
dilution in sterile SB to the appropriate challenge dose [18,41].
I.p challenge was performed by injecting mice i.p. with 100–200 ml
of inoculum. Mice in the pneumonia/sepsis study were anesthe-
tized with Nembutal (pentobarbitone sodium, Rhone-Merieux)
and challenged intranasally (i.n.) with 50 ml of inoculum, as
previously described [18,38,39]. The actual challenge doses were
determined retrospectively by plating on BA with or without
antibiotic selection, as appropriate. For survival studies, mice were
monitored closely over a 3 week period following challenge for
signs of disease and the survival time of each mouse was recorded.
Inoculation of the mice in the i.p. and pneumonia/sepsis
competition studies was performed as for the former studies, but
a combination of wild-type (Ery
s) and mutant (Ery
r) was used. For
the i.n. colonization competition study, transparent phase bacteria
were grown in THY to mid-logarithmic phase (A600=0.5) [18,41].
Mutant (Ery
r) and wild-type (Ery
s) cultures were then concentrated
10-fold, combined, and 10 ml was used to inoculate each mouse
i.n. without anaesthesia. For all competition studies, the exact
challenge doses and ratio of mutant to wild-type (input ratio) was
determined retrospectively by duplicate plating on BA and BA-
Ery. Mice were sacrificed by CO2 asphyxiation and nasal wash,
ear wash, nasal tissue, lung, and blood samples were taken where
appropriate and processed as previously described [18,38,39,41].
Samples were plated onto BA and BA-Ery to determine the ratio of
mutant to wild-type (output ratio) for each niche at each time
point. Competitive Index (CI) was calculated as output ratio/input
ratio.
Sulfatase assay
The assay was conducted using 4-methylumbelliferyl sulfate
potassium salt (Sigma-Aldrich) and limpet sulfatse (Sigma-Aldrich)
as a positive control, as previously described [25], with the
exception that bacteria were grown in BHI and lysed by either a
French pressure cell (SLM Instruments, Urbana, IL, USA)
operated at 12,000 psi or with 0.1% (w/v) sodium deoxycholate
(BDH Biochemicals, Poole, United Kingdom).
Bioinformatic analysis
In this study, the sequence of the accessory region encoding a
putative cellobiose PTS was taken from either Streptococcus pneumoniae
Hungary19A-6 (CP000936.1; nucleotides 1784680–1794642) or
OXC141 (FQ312027.1; nucleotides 1602906–1612886). BLAST
(basic local alignment search tool) analysis was performed through
the websites of the National Center for Biotechnology Information
Virulence of a Pneumococcal PTS Mutant
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[42,43]. Searches of the Pfam database (version 25.0) were also
performed, as well as on the HHpred server [44,45].
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